Santhera Pharmaceuticals Holding AG
SANN
Rangering i aksjer
#16508
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Aksjekurs
$17.84
Markedsverdi
$272.97M
Endring (1 dag)
-6.69%
Endring (1 år)
39.04%
Land
CH
Handel Santhera Pharmaceuticals Holding AG (SANN)
Kategori
Healthcare
Historikk for aksjesplitt for Santhera Pharmaceuticals Holding AG (SANN)
Aksjen Santhera Pharmaceuticals Holding AG (symbol: SANN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én SANN-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 SANN-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én SANN-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 SANN-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
